Study of Capsaicin Patch for the Management of Peripheral Neuropathic Pain
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The efficacy and safety of the low concentration [0.65% (50 µg/cm2) and 1.25% (100 µg/cm2)]
capsaicin patches and compared them to conventional 0.075% capsaicin cream and placebo patch
in patients suffering from peripheral neuropathy